CBAOF(CBAOF)
CBAOF
No analyst ratings available
No analyst price targets available for CBAOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $5.74B | $6.20B |
| Low | $5.74B | $6.20B |
| High | $5.74B | $6.20B |
| EBITDA Avg | $5.21B | $5.63B |
| Low | $5.21B | $5.63B |
| High | $5.21B | $5.63B |
| EBIT Avg | $5.18B | $5.59B |
| Low | $5.18B | $5.59B |
| High | $5.18B | $5.59B |
| Net Income Avg | $3.65B | $4.07B |
| Low | $3.65B | $4.07B |
| High | $3.65B | $4.07B |
| EPS Avg | $4.69 | $5.23 |
| Low | $4.69 | $5.23 |
| High | $4.69 | $5.23 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $856M | $821M | $863M | $884M | $893M | $888M | $893M | $958M |
| Low | $856M | $821M | $863M | $884M | $893M | $888M | $893M | $958M |
| High | $856M | $821M | $863M | $884M | $893M | $888M | $893M | $958M |
| EBITDA Avg | $777M | $745M | $783M | $802M | $810M | $806M | $810M | $869M |
| Low | $777M | $745M | $783M | $802M | $810M | $806M | $810M | $869M |
| High | $777M | $745M | $783M | $802M | $810M | $806M | $810M | $869M |
| EBIT Avg | $772M | $741M | $778M | $797M | $806M | $801M | $805M | $864M |
| Low | $772M | $741M | $778M | $797M | $806M | $801M | $805M | $864M |
| High | $772M | $741M | $778M | $797M | $806M | $801M | $805M | $864M |
| Net Income Avg | $481M | $553M | $607M | $729M | $850M | $484M | $479M | $517M |
| Low | $481M | $553M | $607M | $729M | $850M | $484M | $479M | $517M |
| High | $481M | $553M | $607M | $729M | $850M | $484M | $479M | $517M |
| EPS Avg | $0.61 | $0.70 | $0.77 | $0.93 | $1.08 | $0.62 | $0.61 | $0.66 |
| Low | $0.61 | $0.70 | $0.77 | $0.93 | $1.08 | $0.62 | $0.61 | $0.66 |
| High | $0.61 | $0.70 | $0.77 | $0.93 | $1.08 | $0.62 | $0.61 | $0.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |